User login
- /content/bevacizumab-plus-irinotecan-beats-temozolomide-stalling-glioblastoma
- /oncologypractice/article/59008/neuro-oncology/bevacizumab-plus-irinotecan-beats-temozolomide
- /hematology-oncology/article/59008/neuro-oncology/bevacizumab-plus-irinotecan-beats-temozolomide
- /neurology/article/59008/neuro-oncology/bevacizumab-plus-irinotecan-beats-temozolomide-stalling
- /clinicalneurologynews/article/59008/neuro-oncology/bevacizumab-plus-irinotecan-beats-temozolomide